Independent advisers to the FDA endorsed the pill, molnupiravir, in an unusually tight 13-10 vote this week after airing concerns about its low efficacy rate and potential safety risks to pregnant people.Read More

Independent advisers to the FDA endorsed the pill, molnupiravir, in an unusually tight 13-10 vote this week after airing concerns about its low efficacy rate and potential safety risks to pregnant people.Read More